Efficient isolation and elution of cellular proteins using aptamer-mediated protein precipitation assay by Kim, K et al.
Biochemical and Biophysical Research Communications 448 (2014) 114–119Contents lists available at ScienceDirect
Biochemical and Biophysical Research Communications
journal homepage: www.elsevier .com/locate /ybbrcEfﬁcient isolation and elution of cellular proteins using
aptamer-mediated protein precipitation assayhttp://dx.doi.org/10.1016/j.bbrc.2014.04.086
0006-291X/ 2014 Elsevier Inc. All rights reserved.
⇑ Corresponding author. Fax: +82 54 279 8245.
E-mail address: kiseokkim@aptsci.com (K. Kim).Kiseok Kim a,⇑, SeungJin Lee a, Sungho Ryu a,b, Dongil Han a
aAptamer Sciences Inc., Postech Biotech Center, San31 Hyoja-Dong, Pohang, Kyungbuk 790-784, Republic of Korea
bDivision of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang, Kyungbuk 790-784, Republic of Korea
a r t i c l e i n f o a b s t r a c tArticle history:
Received 9 April 2014
Available online 24 April 2014
Keywords:
Aptamer
SELEX
Isolation
Protein precipitation
Dextran sulfateProtein precipitation is one of the most widely used methods for antigen detection and puriﬁcation in
biological research. We developed a reproducible aptamer-mediated magnetic protein precipitation
method that is able to efﬁciently capture, purify and isolate the target proteins. We discovered DNA apta-
mers having individually high afﬁnity and speciﬁcity against human epidermal growth factor receptor
(EGFR) and human insulin receptor (INSR). Using aptamers and magnetic beads, we showed it is highly
efﬁcient technique to enrich endogenous proteins complex and is applicable to identify physiologically
relevant protein–protein interactions with minimized nonspeciﬁc binding of proteins. The results pre-
sented here indicate that aptamers would be applicable as a useful and cost-effective tool to identify
the presence of the particular target protein with their speciﬁc protein partners.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Aptamers are single-stranded oligonucleotides that form stable
three-dimensional structures capable of binding with high afﬁnity
and speciﬁcity to a variety of molecular targets. Aptamers against a
speciﬁc target are generated using an iterative approach called
SELEX (Systematic Evolution of Ligands by Exponential Enrich-
ment) [1]. Aptamers have advantages over more antibodies in that
they are poorly immunogenic, stable, and often bind to a target
molecule more strongly than do antibodies. Furthermore, produc-
ing an aptamer is more cost-advantageous than an antibody
because it can be synthesized easily and in large quantities by
in vitro transcription, PCR, or chemical synthesis [2,3]. Aptamers
have been shown to be useful as therapeutic agents [4], diagnostic
tools [4], biochemical detection [5], and afﬁnity-puriﬁcation [6,7].
Antibodies are widely used as a tool in protein identiﬁcation
and quantiﬁcation methods. Immunoprecipitation (IP) is one of
the most widely used methods for antigen detection and puriﬁca-
tion. An important characteristic of IP reactions is their potential to
deliver not only the target protein, but also other cellular proteins
that interact with the target. IP of intact protein complexes (i.e.
antigen along with any proteins or ligands that are bound to it)
is known as co-immunoprecipitation (Co-IP). Co-IP is a popular
technique to identify physiologically relevant protein–proteininteractions by using target protein-speciﬁc antibodies. However,
most commonly encountered problems with IP and Co-IP approach
is interference from antibody heavy and light chains in gel analysis.
Co-precipitated antibody with the target can obscure the results.
The ideal situation would be to conduct the Co-IP without contam-
ination of the eluted antigen with antibody. Aptamer is an oligonu-
cleotide that will not contribute to protein/peptide background
that can interfere with subsequent analysis.
In this study, the aptamer-mediated cellular protein precipita-
tion which is a technique to identify physiologically relevant pro-
tein–protein interactions by using target protein-speciﬁc
aptamers is provided. This assay is performed by using both apt-
amer–conjugated magnetic agarose beads and biotinylated apt-
amer with streptavidin-coated magnetic beads, and conﬁrmed its
superior performance over antibody based methods.2. Materials and methods
2.1. Modiﬁed systematic evolution of ligands by exponential
enrichment (SELEX)
The advanced SELEX technology was used as described by
Gold et al. [1]. Brieﬂy, aptamers were selected from a DNA library
containing a 40-nucleotide randomized region in which 5-(N-ben-
zylcarboxyamide)-20-deoxyuridine (Bz-dU) or 5-(N-naphthylcarb-
oxyamide)-20-deoxyuridine (Nap-dU) was substituted for dT. The
oligonucleotides contained a central randomized region of 40
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tides (50-GAGTGACCGTCTGCCTG-40N-CAGCCACACCACCAGCC-30).
Twenty-ﬁve thermal cycles were conducted at 93 C for 30 s, 52 C
for 20 s, and 72 C for 60 s. The SELEX process was performed at
37 C. A mixture of 1 mmol of aptamer library dissolved in a buffer
solution (40 mM HEPES/pH 7.5, 120 mM NaCl, 5 mM KCl, 5 mM
MgCl2, 0.002% Tween 20) was heated at 95 C for about 3 min, and
then slowly cooled to 37 C at 0.1 C/s for re-folding. Aptamer library
was pre-incubated with His tag magnetic bead (Invitrogen, Grand
Island, NY) to eliminate non-speciﬁc binder to magnetic bead. Apt-
amer library in supernatant were incubated with puriﬁed 10 pmol
of target proteins for 30 min and then target proteins captured by
contacting with His tagged beads for 10 min. Aptamers bound to
the target proteins were eluted with 2 mM NaOH solution and
ampliﬁed via PCR reaction. The resulting aptamers were used in
the next SELEX round.
2.2. Cloning and sequencing of selected aptamers
After 8 rounds of SELEX, eluted aptamers were ampliﬁed by
QPCR using primers, and then cloned into TA cloning Kit (Solgent,
Korea). Fifty colonies were picked for each sample and the cloned
parts were sequenced by Solgent. Sequences were aligned using
the ‘aptamer motif searcher’, an in-house program of Aptamer Sci-
ences Inc., and a pattern analysis was performed.
2.3. Binding afﬁnity assays
The aptamer–protein equilibrium dissociation constants (Kd)
were determined by the nitrocellulose-ﬁlter binding method [8].
For all binding assays, aptamers were dephosphorylated using
alkaline phosphatase (New England Biolab, Beverly, MA), 5-end
labeled using T4 polynucleotide kinase (New England Biolabs)
and [32P]-ATP (Amersham Pharmacia Biotech, Piscataway, NJ) [9].
Direct binding assays were carried out by incubating 32P-labeled
aptamer at a concentration of less than 10 pM and protein at con-
centrations ranging from 1 mM to 10 fM in selection buffer at
37 C. The fraction of bound aptamer was quantiﬁed with a Phos-
phorImager (Fuji FLA-5100 Image Analyzer, Tokyo, Japan). Raw
binding data were corrected for nonspeciﬁc background binding
of radiolabeled aptamer to the nitrocellulose ﬁlter.
2.4. Cell culture
The human skin carcinoma cell line (A431) and Rat-1 cells
stably expressing the human insulin receptor (Rat-1/INSR) were
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Invitro-
gen) supplemented with 10% fetal bovine serum (Gibco, Grand
Island, NY), 10 U/mL penicillin and 10 lg/mL streptomycin (Gibco)
in a 5% CO2-humidiﬁed chamber at 37 C.
2.5. Conjugation of magnetic agarose bead with aptamers
Antibodies were immobilized to Magnetic beads (Dynabeads
M270 amine) (#143-07D, Invitrogen) according to the manufac-
turer’s instructions. Thiol aptamers (SH-aptamers) were conju-
gated to amino magnetic agarose beads (BioScience Beads
Division, RI). Pack 0.5 ml magnetic beads in column or centrifuge
tube and wash thoroughly with activation buffer (1 M NaCl,
0.05 M NaHPO4, 1 mM EDTA pH 7.4). The beads were prepared
50% suspension in the column with the activation buffer and added
iodoacetic NHS (FW 283; Sigma/Aldrich #I9760) to 15 lmol/ml
packed gel. Beads were incubated with shaking for 2 h at ambient
temperature. Acetic anhydride was added in a ﬁnal concentration
of 0.05 M in the 50% suspension. Beads were washed with coupling
buffer (1 M NaCl, 0.05 M-Bicarb-NaOH, 1 mM EDTA pH 9.0). Theactivated thiol aptamer was added directly to the activated mag-
netic beads under N2 and allowed to couple overnight.
2.6. Aptamer-mediated cellular protein precipitation
(aptoprecipitation, AP) assay
About 4  106 cells (70–80% conﬂuence) in 100 mm culture dish
were solubilized in lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl,
5 mMMgCl2, 1 mM EDTA, 5% glycerol, 1% NP-40) containing prote-
ase inhibitor cocktail (Roche), and the cell lysates were incubated
on ice for 10 min. The cell lysates were clariﬁed by centrifugation
at 12,000g for 10 min at 4 C after brief sonication. The cleared
lysates were mixed with either biotinylated aptamer or aptamer–
magnetic agarose beads, 200 lg/ml salmon sperm DNA (ssDNA)
(Ambion), and ﬁnal 1 mM dextran sulfate (DxSO4, Framingham,
MA, USA). After incubating for 2 h or overnight at 4 C, the mixed
solution washed four times with detergent-free wash buffer.
2.7. Aptamer-mediated cellular protein co-precipitation (Co-
aptoprecipitation, Co-AP) assay
Cells were starved to serum-free medium overnight (16–18 h)
and were stimulated with 100 nM insulin (Sigma–Aldrich, ON,
Canada) or EGF (Sigma–Aldrich) for 5 min at 37 C. Cell monolayers
were washed twice with phosphate buffered saline (PBS) and lysed
into lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM MgCl2,
1 mM EDTA, 5% glycerol, 1% NP-40) containing protease inhibitor
cocktail and phosphatase inhibitor cocktail (Roche) by incubation
for 30 min on ice. The cell lysates were clariﬁed by centrifugation
at 12,000g for 10 min at 4 C. The cleared lysates were mixed with
aptamer–magnetic agarose beads, 200 lg/ml ssDNA, and ﬁnal
0.01 mM dextran sulfate. After incubating overnight at 4 C, the
mixed solution washed four times with detergent-free lysis buffer.
2.8. Elution of target proteins
The bound proteins were eluted by 20 mM Triethylamine (TEA),
pH 11.3 for 15 min at 25 C with gentle mixing. Place the tube on a
magnetic stand and transfer the supernatant to new tube and add
3 ll of 2 M Tris–HCl (pH 7.0) to the supernatant for the neutraliza-
tion and mix immediately.
2.9. SDS–PAGE and Western blot
Total cell lysates or eluate were boiled in a loading buffer and
subjected to SDS–PAGE (4–15% gradient gel) and stained by SYPRO
ruby proteins (Invitrogen). Stained images were visualized using a
Fuji FLA-5100 Image Analyzer. For Western blot analysis, samples
were subjected to SDS–PAGE and blotted onto nitrocellulose mem-
branes. After blocking in 5% skim milk in TBS-T (50 mM Tris–HCl,
pH 7.5, 150 mM NaCl, 0.05% Tween 20), membranes were probed
with speciﬁc antibodies and proteins were visualized with peroxi-
dase-coupled secondary antibodies using the ECL system
(Amersham Biosciences).
3. Results and discussion
3.1. Generation of anti-EGFR and INSR aptamers with high afﬁnities
via advanced SELEX using a modiﬁed nucleoside
In order to generate DNA aptamers against EGFR (ErbB-1) or
INSR, we used a truncated each protein containing the extracellular
domain that was expressed in mouse myeloma cell line. For INSR-
binding aptamers, a His-tagged fusion of the extracellular domain
(28–750 amino acids (a subunit) and 751–944 with a C-terminal
Table 2
Binding afﬁnities (Kd values) of aptamers against INSR proteins.
INSR aptamers 1652-17 1652-18 1652-36 1652-49
Kd (nM) 2.8 10 7.9 3.3
Table 3
Sequences of the EGFR and INSR binding aptamers used for AP and Co-AP assay. ‘5’
indicates the 5-Bz-dU-modiﬁed oligonucleotide and ‘6’ indicates the 5-Nap-dU-
modiﬁed oligonucleotide of aptamers.
Clone Sequence
2369-27-2 AGTTCAGCCCCGG66A6ACGG6C6CA6GCC6G6GCG66
6AACC6AGACCA
1652-49 GCCTG5AAGG555AAGC55GGCC5AA5GG5GC5A5CAGGC5C
Fig. 1. Reduction of nonspeciﬁc proteins using dextran sulfate. A431 cell lysates
(1 mg/lane) were incubated with biotinylated EGFR aptamers (2369-27-2)
(20 pmol) and dextran sulfate. The mixed solution was further incubated with
streptavidin magnetic beads. Gels were stained with SYPRO Ruby. Lane 1 indicates
size marker. Lane 2 indicates A431 cell lysates corresponding to 20 lg of total
cellular proteins. Lane 3 indicates Blank lane. Lanes 4–7 indicate eluate by boiling
SDS loading buffer after AP with different concentration of dextran sulfate ranging
from 0 to 1.0 mM.
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tioned on Talon (Dynal, Lake Success, NY) beads. For EGFR-binding
aptamers, an Fc fusion of the extracellular domain (100–330 amino
acids) (R&D Systems, #344-ER) was biotinylated and partitioned
on streptavidin MyOne-SA (Dynal) beads. Advanced SELEX, using
Bz-dU or Nap-dU instead of Thymidine, was performed to acquire
aptamers with high afﬁnity and speciﬁcity [1,9,10].
The aptamers against the EGFR and INSR were obtained from a
pool of 1  1014 DNAs that consisted of a 40-nt randomized region
with 17 and 17 primer sequences for PCR ampliﬁcation. The DNA
pool was mixed with the target proteins and then the target pro-
teins–DNA complex was captured on a nitrocellulose ﬁlter. Selec-
tions were carried out with gradual reductions in the protein
quantity and the DNA amounts in each round. After 8 rounds of
selection, four aptamers (2369-1-1, -11-1, -12-1, -27-1) with high
afﬁnities to the puriﬁed EGFR proteins were obtained (Table 1), and
three aptamers (1652-17, -18, -36) with high afﬁnities to the puri-
ﬁed INSR proteins were obtained (Table 2). The afﬁnity values of
aptamers ranged Kd = 0.6–12 nM. As a result of a secondary struc-
ture prediction study of the 2369-27-1 and 1652-17 clones with a
web-based program Mfold, a minimized 2369-27-2 and 1652-49
were successfully obtained without any loss of the binding ability
to the EGFR and INSR, respectively (Tables 1 and 2). These 2369-
27-2 and 1652-49 clones were used for the following AP and Co-
AP assay and the sequence data for these clones are presented in
Table 3. Aptamers were synthesized on an automated solid phase
DNA synthesizer. A 0.1 M solution of phosphoramidite in anhy-
drous acetonitrile was used for the synthesis. All of the oligonucle-
otides were characterized by LC ESI-MS and the purity was
assessed by HPLC and capillary electrophoresis.
3.2. Reduction of nonspeciﬁc proteins using polyanionic competitor
To reduce background nonspeciﬁc proteins encountered in apt-
amer-mediated cellular protein precipitation, the AP experiment
using EGFR aptamer (2369-27-2) was conducted using dextran sul-
fate as a competitor. Different concentrations of dextran sulfate
ranging from 0.01 to 1.0 mM were used to block nonspeciﬁc pro-
teins in cell lysates (Fig. 1). EGFR bands were detected and nonspe-
ciﬁc protein bands were reduced at an increased concentration of
dextran sulfate. This result indicates that dextran sulfate can
reduce nonspeciﬁc proteins in AP assays, thereby allowing highly
speciﬁc interaction between the aptamers and the EGFR. We rea-
soned that a polyanionic competitor would substantially reduce
nonspeciﬁc binding. Modiﬁed aptamers contain novel base modiﬁ-
cations (Bz-dU or Nap-dU) that mediate hydrophobic interactions
at the protein–aptamer interface, thereby achieving high afﬁnity
binding. Modiﬁed aptamers are selected using a kinetic challenge
with dextran sulfate, thus favoring slow target dissociation rates
and minimizing ionic contributions to binding. Our results are in
good agreement with the result work of Shashi et al. [11] reported
that dextran sulfate is useful for reducing background of nonspe-
ciﬁc proteins in immunohistochemistry.
3.3. Performance of biotinylated aptamer in protein precipitation
assay
In order to compare the performance of aptamers and antibod-
ies in cellular protein precipitation assays, A431 cell lysates thatTable 1
Binding afﬁnities (Kd values) of aptamers against EGFR proteins.
EGFR aptamers 2369-1-1 2369-11-1
Kd (nM) 11.7 6.3express the human EGFR were incubated with biotinylated EGFR
aptamers and dextran sulfate, followed by incubation with strepta-
vidin magnetic beads as described in Section 2. As shown in Fig. 2A,
EGFR proteins were precipitated from A431 cell extract using the
biotinylated EGFR aptamer. An intense EGFR band was clearly
obtained by using the biotinylated EGFR aptamer, while a rela-
tively weak EGFR band was obtained when precipitating with
anti-EGFR antibody. An intense EGFR band was also obtained with
high-pH elution buffer (20 mM TEA, pH 11.3).
Protein precipitation assays were also performed with Rat-1/
INSR cell overexpressing insulin receptors. Brieﬂy, Rat-1/INSR cell
lysates that express the human INSRwere incubatedwith biotinyla-
ted INSR aptamers (1652-49) and dextran sulfate, followed by incu-
bation with streptavidin magnetic beads as described in Section 2.
Fig. 2B shows that the INSR proteins were precipitated from Rat-1/
INSR cell extract using the biotinylated INSR aptamer. An intense2369-12-1 2369-27-1 2369-27-2
7.1 0.62 0.99
Fig. 2. Aptoprecipitation of target proteins with biotinylated aptamers. AP of EGFR protein with biotinylated EGFR aptamer (2369-27-2) (A). A431 cell lysates (1 mg/lane)
were incubated with either biotinylated EGFR aptamers (20 pmol) or anti-EGFR antibody (20 pmol). The mixed solution was further incubated with either streptavidin
magnetic beads for aptamer or Protein-A bead for antibody. AP of INSR protein with biotinylated INSR aptamer (1652-49) (B). Rat-1/INSR cell lysates (1 mg/lane) were
incubated with either biotinylated INSR aptamers (40 pmol) or anti-INSR antibody (40 pmol). The mixed solution was further incubated with either streptavidin magnetic
beads for aptamer or Protein-A bead for antibody. The bound protein was eluted in either SDS-sample buffer (eluate 1) or high-pH elution buffer (20 mM TEA, pH 11.3) (eluate
2) and separated by SDS–PAGE (4–15% gradient gel). The gel was directly stained with SYPRO ruby. TCL: total cell lysate.
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biotinylated INSR aptamer, while a relatively weak INSR band was
detected when precipitating with anti-INSR antibody. An intense
INSR bands (INSRa and INSRb) were also obtained by high-pH elu-
tion buffer. Both INSRa and INSRb proteins were precipitated from
Rat-1/INSR cells but not from Rat-1 cells when precipitating with
either INSR aptamer or antibody. These results indicate that the bio-
tinylated aptamers efﬁciently precipitate target proteins from a
complex protein mix, while antibodies precipitate extraordinarily
small amounts of target proteins and the performance of aptamers
in terms of speciﬁcity and selectivity is signiﬁcantly superior com-
pared to antibodies in protein precipitation assays.
3.4. Performance of aptamer-magnetic agarose beads in protein
precipitation assay
To compare the performance of aptamers and antibodies conju-
gated magnetic bead, A431 cell lysates that express the humanFig. 3. Aptoprecipitation of target proteins with aptamer–magnetic agarose beads. AP of E
lysates (1 mg/lane) were incubated with either EGFR aptamer (50 pmol)–magnetic agar
bound protein was eluted in either SDS-sample buffer (eluate 1), high-pH elution buffer
INSR protein with INSR aptamer (1652-49)–magnetic agarose beads (B). Rat-1/INSR cells
agarose bead or anti-INSR antibodies (50 pmol)-magnetic bead (Dynabead M270). The
buffer (eluate 2, aptamer) or low-pH elution buffer (eluate 3, antibodies). Proteins were se
ruby (upper image). Proteins were also blotted onto a PVDF membrane and Western blo
complement sequence of EGFR or INSR aptamer)–coupled magnetic agarose beads is usEGFR were incubated with either EGFR aptamer (2369-27-2)-mag-
netic agarose beads or EGFR antibody-magnetic beads as described
in Section 2. As shown in Fig. 3A, it should be noted that many pro-
teins which are not related with EGFR were detected in IP with
antibody from bead-bound proteins (lanes 6–7) and the proteins
eluted from the bead (lane 8). Moreover, EGFR protein was not
clearly detected from IP with antibody. On the other hand, much
less non-speciﬁc protein-binding was observed in AP with aptamer
from bead-bound proteins (lane 3) and the proteins eluted from
the bead (lane 4) without sacriﬁcing speciﬁc binding of EGFR. EGFR
aptamers were highly speciﬁc to EGFR, while anti-EGFR antibody
precipitated extraordinarily small amounts of EGFR.
Protein precipitation assays were performed with another Rat-
1/INSR cell expressing insulin receptors. Rat-1/INSR cell lysates
that express the human INSR were incubated with either INSR apt-
amer (1652–49)-magnetic agarose beads and INSR antibody-mag-
netic beads as described in Section 2. As shown in Fig. 3B (upper
data), it should be noted that many proteins which are not relatedGFR protein with EGFR aptamer (2369-27-2)–magnetic agarose beads (A). A431 cell
ose beads or anti-EGFR antibody (50 pmol)-magnetic beads (Dynabead M270). The
(20 mM TEA, pH 11.3) (eluate 2) or low-pH elution buffer (pH 4.0) (eluate 3). AP of
lysates (1 mg/lane) were incubated with either INSR aptamer (50 pmol)–magnetic
bound protein was eluted in either SDS-sample buffer (eluate 1), high-pH elution
parated by SDS–PAGE (4–15% gradient gel). The gel was directly stained with SYPRO
t was probed with speciﬁc antibodies (lower image). Blank bead: aptamer (reverse
ed as a control.
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teins (lanes 4–5) and the protein eluted from the bead (lanes 7–8).
On the other hand, much less non-speciﬁc protein-binding was
observed in AP with aptamer from bead-bound proteins (lane 3)
and the proteins eluted from the bead (lane 6) without sacriﬁcing
speciﬁc binding of INSR-a and INSR-b. INSR aptamers were highly
speciﬁc to INSR, while anti-INSR antibody precipitated extraordi-
narily small amounts of EGFR. To identify aptoprecipitated target
proteins, Western blot analysis was performed (Fig. 3B, below
data). As a result, all INSRa, INSRb, and INSR precursor were iden-
tiﬁed in AP with aptamer under both boiled and eluted samples,
while any of INSR proteins were not detected in IP with antibody
(Santa cruz anti-Irb). However, all INSRa, INSRb, and INSR precur-
sor were detected by anti-IRa (Invitrogen) under both boiled and
eluted samples. These results indicated that aptamers demonstrate
less interference and higher speciﬁcity than antibodies in protein
precipitation assays.3.5. Identiﬁcation of physiologically relevant protein–protein
interactions using aptamers
To verify the performance of EGFR aptamers in Co-AP assay,
A431 cells were starved to serum-free medium overnight
(16–18 h) and were stimulated with 100 nM EGF (Sigma–Aldrich).
A431 cell lysates were incubated with EGFR aptamer (2369-27-2)-
magnetic agarose beads and dextran sulfate as described in Sec-
tion 2. As shown in Fig. 4A, EGFR interacting proteins such asFig. 4. Co-aptoprecipitation of target proteins and their interacting proteins with
aptamer–magnetic agarose beads. Co-AP of EGFR and their interacting proteins
from A431 cell lysate using aptamer–magnetic agarose bead (A). Subconﬂuent A431
cell culture was starved overnight and stimulated with 100 nM EGF. A431 cell
lysates (1 mg/lane) were incubated with either EGFR aptamer (200 pmol)–magnetic
agarose beads or control EGFR aptamer (200 pmol)–magnetic agarose beads. The
bound protein was eluted and separated with SDS–PAGE and blotted onto a PVDF
membrane. The membrane was probed with speciﬁc antibodies [anti-EGFR Ab (Cell
signaling #2232), anti-PLC-c1 Ab (R&D systems #MAB3288), anti-Shc Abs (Cell
signaling #2432), anti-PI3K Ab (Santa cruz #sc-1637), anti-Akt Ab (Cell signaling
#4691), and anti-Grb2 Abs (R&D systems #MAB3846)]. Co-AP of INSR and their
interacting proteins from Rat-1/INSR cell lysate using aptamer–magnetic agarose
beads (B). Subconﬂuent Rat-1/INSR cell culture was starved overnight and
stimulated with 100 nM insulin. Rat-1/INSR cell lysates (1 mg/lane) were incubated
with either INSR aptamer (200 pmol)–magnetic agarose bead or control EGFR
aptamer (200 pmol)–magnetic agarose beads. The samples were separated by SDS–
PAGE and blotted onto a PVDF membrane. The membrane was probed with speciﬁc
antibodies [anti-IR b Ab (Cell signaling #3025), anti-IRS1 Ab (Millipore #06-248),
anti-Akt Ab (Cell signaling #4691), anti-PI3K Ab (Santa cruz #sc-1637), anti-Shc Abs
(Cell signaling #2432)]. TCL: total cell lysate. Control aptamer: reverse complement
sequence of EGFR or INSR aptamer–coupled magnetic agarose beads is used as a
control.PLC-c1, Shc, PI3K, Akt2, and Grb2 were identiﬁed in aptamer-med-
iated Co-AP assay, while none of EGFR interacting proteins was
detected with control aptamer–magnetic agarose beads. The PLC-
c1, Shc, PI3K, Akt2, and Grb2 proteins have been implicated in
EGFR signaling. The binding of EGF at the cell surface induces
dimerization of EGFR, which results in the activation of EGFR tyro-
sine kinase activity and trans-autophosphorylation. Sites of tyro-
sine autophosphorylation in an activated EGFR bind signaling
proteins that contain phosphotyrosine (pTyr)-binding domains
such as Src homology 2 and phosphotyrosine binding [12,13].
These signaling proteins include Grb2, Shc, PLC-c1, PI3K and
Akt2 [14,15].
To verify the performance of INSR aptamers, Co-AP was per-
formed with another Rat-1/INSR cell expressing insulin receptors.
Rat-1/INSR cells were starved to serum-free medium overnight
(16–18 h) and were stimulated with 100 nM insulin (Sigma–
Aldrich). Rat-1/INSR cell lysates were incubated with INSR aptamer
(1652-49)-magnetic agarose beads and dextran sulfate as
described in Section 2. As a result, INSRb was clearly detected in
Co-AP eluted proteins from bead-bound proteins, while INSRb pro-
tein was not detected with control aptamer–magnetic agarose
beads (Fig. 4B). INSR interacting proteins such as IRS-1, PI3K,
Akt2, and Shc were identiﬁed in aptamer-mediated Co-AP assay,
while any of INSR interacting proteins were not clearly detected
with control aptamer–magnetic agarose beads.
The IRS-1, Shc, PI3K, and Akt2 proteins have been implicated in
insulin receptor (INSR) signaling. Identiﬁcation of the phosphoino-
sitide-3-kinase–protein kinase B/Akt (PI3K-PKB/Akt) pathway and
activating receptor tyrosine kinases (RTKs) began in earnest in
the early 1980s through vigorous attempts to characterize INSR
[16]. These led to the identiﬁcation of the components and mech-
anism of INSR signaling via INSR substrate (IRS) proteins to PI3K
and consequent PKB/Akt-mediated activation by 3-phosphoinosi-
tide-dependent protein kinase 1 (PDK1). The Shc proteins have also
been implicated in INSR signaling. It was demonstrated by using
sensitive two-hybrid assay of protein–protein interaction that
SHC interacts directly with the INSR. SHC interacts directly with
the INSR and that phosphorylation of Tyr-960 within the INSR juxt-
amembrane domain is necessary for efﬁcient interaction [17].
We succeeded in generating DNA aptamers that target EGFR
and INSR proteins in cells with high afﬁnity and speciﬁcity. Fur-
thermore, we developed a reproducible aptamer-mediated protein
precipitation technique that is a novel sample preparation tool
used for concentration, and isolation of a particular protein from
complex biological samples and is applicable to identify physiolog-
ically relevant protein–protein interactions. AP and Co-AP experi-
ments indicated that the binding afﬁnities of EGFR and INSR
aptamers were remarkably higher than those of anti-EGFR and
INSR antibodies (Figs. 2 and 3).
Since aptamer is an oligonucleotide that will not contribute to
protein background that can interfere with subsequent analysis,
we will evaluate to detect the proteins speciﬁc to the EGFR includ-
ing many known and (potentially) novel interactors as well as
some EGFR posttranslational modiﬁcations (PTMs).
Our aptamers showed signiﬁcant and speciﬁc binding to their
target proteins in aptamer-mediated AP and Co-AP assays that
can be a useful tool for the studies of physiologically relevant pro-
tein–protein interactions. These aptamers have potential use in the
quantitative analysis of the amount of target proteins with the
double-aptamer sandwich detection. These aptamers have another
potential use in the cell separation assays. Efﬁcient selection and
enumeration of low-abundance biological cells are highly impor-
tant in a variety of applications. Aptamer-mediated cell separation
technology may provide the speciﬁcity of monoclonal aptamers for
effortless separation of highly puriﬁed cells that are immediately
ready for downstream applications. Cells are captured by magnetic
K. Kim et al. / Biochemical and Biophysical Research Communications 448 (2014) 114–119 119particles using aptamer, and then easily separated from unwanted
cells with a magnet. Furthermore aptamers bind to target proteins
with native conformational structure, while antibodies are difﬁ-
cult, so such approaches will gives big advantages for low-abun-
dance-cell isolation and enumeration.
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